PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.18%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.63%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-11.36%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-11.36%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10.69%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-9.76%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-10.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.22%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
1.20%
Dividend growth under 50% of INTC's 24.54%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-38.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-73.49%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
19.20%
10Y revenue/share CAGR under 50% of INTC's 131.51%. Michael Burry would suspect a lasting competitive disadvantage.
47.21%
5Y revenue/share CAGR at 75-90% of INTC's 53.72%. Bill Ackman would encourage strategies to match competitor’s pace.
60.39%
3Y revenue/share CAGR 1.25-1.5x INTC's 48.30%. Bruce Berkowitz might see better product or regional expansions than the competitor.
839.85%
10Y OCF/share CAGR above 1.5x INTC's 59.03%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
422.47%
5Y OCF/share CAGR above 1.5x INTC's 103.76%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
199.68%
3Y OCF/share CAGR above 1.5x INTC's 37.27%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
243.23%
Net income/share CAGR above 1.5x INTC's 82.54% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
183.91%
5Y net income/share CAGR at 75-90% of INTC's 221.23%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
427.26%
3Y net income/share CAGR above 1.5x INTC's 66.09%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
154.02%
10Y equity/share CAGR at 50-75% of INTC's 220.28%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
-3.52%
Negative 5Y equity/share growth while INTC is at 6.85%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
10.46%
3Y equity/share CAGR 1.25-1.5x INTC's 8.69%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
43.45%
Below 50% of INTC's 2031.88%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
44.81%
Below 50% of INTC's 401.22%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
36.80%
Below 50% of INTC's 400.12%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
9.10%
Our AR growth while INTC is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-2.12%
Inventory is declining while INTC stands at 14.11%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.80%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-4.73%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-51.89%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
6.60%
R&D dropping or stable vs. INTC's 14.68%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-0.94%
We cut SG&A while INTC invests at 2.37%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.